So we're looking for a (repeatable) method to screen for subclinical atherosclerosis since a lipid panel, even with newer markers, isn't enough to accurately predict one's risk. It turns out that carotid ultrasound, especially for carotid intima media thickness (CIMT) fits the bill as it is easily performed, non-invasive, repeatable & requires no ionizing radiation. The bigger question then is how well does it detect subclinical atherosclerosis?
Current appropriate use guidelines don't recommend CIMT for low risk or high risk patients, nor for serial monitoring. However, we may soon find it to be useful in those disease populations with greater risk than average. Of course, this restriction is when someone else has to foot the bill. It only costs $150-200 if you can afford to pay out of pocket. Good peace of mind, if you ask me, but again, only if you're willing to commit to a lifestyle change if subclinical atherosclerosis is found. As for me, I don't need a test to tell me what I should be doing anyway.
Tweet
This site complies with the HONcode standard for trustworthy health information:
verify here.
No comments:
Post a Comment